Evidence map›Paper›PMID 27444680›Full record

ArticlePharmaceutical research2016

Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages.

Byeongtaek Oh, Chi H Lee

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. In Vitro Anticancer Activity of Methanolic Extract ofMolecules (Basel, Switzerland) · 2022
    Article
  4. Thiolated Nanoparticles for Biomedical Applications: Mimicking the Workhorses of Our Body.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Byeongtaek OhDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA.
Chi H LeeDivision of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri, 64108, USA. LeeCh@umkc.edu.
University of Missouri–Kansas City · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe current study was designed to develop thiolated-graphene quantum dots (SH-GQDs) as a theranostic nanocarrier and evaluate its potential for the optimal scavenging of reactive oxygen species (ROS) in macrophages.

methodsSH-GQDs were prepared by hydrothermal pyrolysis of carbon source (citric acid) in the presence of reduced-glutathione (GSH). Raw264.7 cells were treated with varying concentrations of oxLDL (0.5, 1 and 2 μg/ml) in the presence or absence of SH-GQDs and cells were stained with peroxide-sensitive fluorescent dye (DCFDA). Flow cytometry analysis was performed to investigate the expression of MSR and ATP-binding cassette transporter (ABCA1) after such treatments as the negative control, oxLDL treatment and oxLDL treatment in the presence of either GQDs or SH-GQDs.

resultsSH-GQDs had a size ranging from 10 to 30 nm with an average size of 21.3 ± 5.2 nm. The elemental analysis indicated that SH-GQDs are mainly composed of carbon, nitrogen, oxygen and sulfur. The expression levels of ABCA1 in macrophages treated with either LDL or oxLDL were lower than those treated with the media control (the negative control: 100 ± 7.6%; LDL: 82.7 ± 1.2%; and oxLDL: 79.2 ± 1.7%). The level of ABCA1 expression increased as cells were incubated with SH-GQDs (SH-GQDs: 101.5 ± 3.1%). The level of MSR on the surface of macrophages upon being treated with SH-GQDs was lower than those with oxLDL (oxLDL: 112.1 ± 8.8% and SH-GQDs: 91.5 ± 4.2%).

conclusionThe enhancement of lipid efflux and down-regulation of MSR in macrophages by SH-GQDs supported its promising usage as a theranostic nanocarrier to prevent foam cell formation and plaque development.

Indexed as

AnimalsApoptosisATP-Binding Cassette TransportersCell SurvivalDown-RegulationDrug CarriersDrug LiberationGlutathioneGraphiteLipoproteins, LDLMacrophagesMiceParticle SizeQuantum DotsRAW 264.7 CellsReactive Oxygen SpeciesATP-Binding Cassette TransportersDrug CarriersGlutathioneGraphiteLipoproteins, LDLoxidized low density lipoproteinReactive Oxygen SpeciesReceptors, ScavengerSulfhydryl Compoundsa theranostic carriermacrophage scavenger receptor (MSR)ROS productionthiolated-graphene quantum dots (SH-GQDs)

Identifiers

PMID27444680
OpenAlexW2485837229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.